October 20, 2011
As regulations governing active pharmaceutical ingredients (APIs) and excipients — including propylene glycols — tighten across the globe, pharmaceutical companies are requiring in-depth quality reviews of the entire supply chain processes for their pharmaceutical raw materials. These companies are considering a variety of solutions, ranging from centralized and decentralized data management systems to risk-based scrutiny and third-party certification. In all cases, the ultimate goal is to strengthen the safety and integrity of the global supply chain while making the most efficient use of resources. Third-party certification holds perhaps the greatest promise as a solution that can help achieve this goal. [More…]
Read the full Dow-contributed story online:
http://www.contractpharma.com/contents/view_features/2011-10-11/supply-chain-focus-purity-matters/
DOW PuraGuard™: Your Security for Purity (3:34)
DOW PuraGuard™: Your Security for Purity (7:38)